Literature DB >> 22184368

Guidelines are too important to be left to clinical experts.

Mattias Johansson1, Pär Stattin.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22184368      PMCID： PMC3273500          DOI： 10.1503/cmaj.111989

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project.

Authors: 
Journal:  Qual Saf Health Care       Date:  2003-02

2.  Prospective validation of active surveillance in prostate cancer: the PRIAS study.

Authors:  Roderick C N van den Bergh; Stijn Roemeling; Monique J Roobol; Wouter Roobol; Fritz H Schröder; Chris H Bangma
Journal:  Eur Urol       Date:  2007-05-25       Impact factor: 20.096

3.  Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors:  Jonas Hugosson; Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Lancet Oncol       Date:  2010-07-02       Impact factor: 41.316

4.  Natural history of progression after PSA elevation following radical prostatectomy.

Authors:  C R Pound; A W Partin; M A Eisenberger; D W Chan; J D Pearson; P C Walsh
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

5.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

6.  Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study.

Authors:  Pär Stattin; Erik Holmberg; Jan-Erik Johansson; Lars Holmberg; Jan Adolfsson; Jonas Hugosson
Journal:  J Natl Cancer Inst       Date:  2010-06-18       Impact factor: 13.506

7.  PCBaSe Sweden: a register-based resource for prostate cancer research.

Authors:  Eva Hagel; Hans Garmo; Anna Bill-Axelson; Ola Bratt; Jan-Erik Johansson; Jan Adolfsson; Mats Lambe; Pär Stattin
Journal:  Scand J Urol Nephrol       Date:  2009

8.  Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

Authors:  Laurence Klotz; Liying Zhang; Adam Lam; Robert Nam; Alexandre Mamedov; Andrew Loblaw
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

9.  Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.

Authors:  Jan Adolfsson; Hans Garmo; Eberhard Varenhorst; Göran Ahlgren; Christer Ahlstrand; Ove Andrén; Anna Bill-Axelson; Ola Bratt; Jan-Erik Damber; Karin Hellström; Magnus Hellström; Erik Holmberg; Lars Holmberg; Jonas Hugosson; Jan-Erik Johansson; Bill Petterson; Magnus Törnblom; Anders Widmark; Pär Stattin
Journal:  Scand J Urol Nephrol       Date:  2007

10.  The basis for monitoring strategies in clinical guidelines: a case study of prostate-specific antigen for monitoring in prostate cancer.

Authors:  Jacqueline Dinnes; Jenny Hewison; Douglas G Altman; Jonathan J Deeks
Journal:  CMAJ       Date:  2011-12-12       Impact factor: 8.262
  10 in total
  1 in total

1.  Are American follow-up recommendations in endocrinology actionable? A systematic review of clinical practice guidelines.

Authors:  Francisco J Barrera; Karina Raygoza-Cortez; Mariana García-Leal; Juan P Brito; Naykky M Singh Ospina; René Rodríguez-Gutiérrez
Journal:  Endocrine       Date:  2021-01-21       Impact factor: 3.633
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.